• Profile
Close

Association between market competition and prices of generic topical dermatology drugs

JAMA Dec 18, 2018

Li DG, et al. - Researchers analyzed retrospectively the cost of the 597 topical dermatologic generic drugs to evaluate the correlation of changes in drug price and the number of US Food and Drug Administration (FDA)-approved manufacturers. They identified the number of manufacturers and the price per unit from the FDA Orange Book and the National Average Drug Acquisition Cost (NADAC) database, respectively, for 2013 through 2016. They observed a negative association between drug price change and the median number of manufacturers indicating a healthy market competition in controlling the costs of generic drug prices within dermatology.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay